Fieldpoint Private Securities’s Gilead Sciences GILD Stock Holding History

Fieldpoint Private Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$92K	Sell	1,481 -924	-38%	-$57.2K	0.03%	382
2022 Q1	$143K	Buy	2,405 +861	+56%	+$55K	0.03%	365
2021 Q4	$112K	Buy	1,544 +989	+178%	+$68.1K	0.02%	423
2021 Q3	$39K	Buy	555 +22	+4%	+$1.55K	0.01%	643
2021 Q2	$37K	Buy	533 +35	+7%	+$2.34K	0.01%	643
2021 Q1	$32K	Sell	498 -80	-14%	-$5.16K	0.01%	671
2020 Q4	$34K	Buy	+578	New	+$34.9K	0.01%	552
2020 Q1	–	Sell	-812	Closed	-$53K	–	363
2019 Q4	$53K	Buy	812 +130	+19%	+$8.47K	0.02%	422
2019 Q3	$43K	Sell	682 -193	-22%	-$12.6K	0.02%	405
2019 Q2	$59K	Hold	875	–	–	0.02%	410
2019 Q1	$57K	Sell	875 -200	-19%	-$13.3K	0.02%	281
2018 Q4	$67K	Sell	1,075 -3,309	-75%	-$231K	0.03%	263
2018 Q3	$338K	Sell	4,384 -275	-6%	-$20.8K	0.13%	161
2018 Q2	$330K	Buy	4,659 +5	+0.1%	+$353	0.13%	158
2018 Q1	$351K	Hold	4,654	–	–	0.16%	131
2017 Q4	$333K	Buy	4,654 +269	+6%	+$20.4K	0.18%	124
2017 Q3	$355K	Buy	+4,385	New	+$335K	0.15%	139
2017 Q2	–	Sell	-525	Closed	-$36K	–	215
2017 Q1	$36K	Buy	+525	New	+$36.9K	0.03%	218

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fieldpoint Private Securities's GILD Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Gilead Sciences (GILD) stake by 38% in Q2 2022, selling an estimated $57.2K and leaving 1,481 shares worth $92K. The position accounts for 0.03% of the portfolio, ranked #382.

Fieldpoint Private Securities first reported a position in GILD in Q1 2017 and has held it in 18 quarters since. The position peaked at $355K in Q3 2017. 1,604 funds tracked by Wall St. Rank hold GILD as of Q2 2022.

Fieldpoint Private Securities held 1,481 shares of Gilead Sciences worth $92K as of Q2 2022.
Fieldpoint Private Securities sold 924 Gilead Sciences shares in Q2 2022, an estimated $57.2K.
Gilead Sciences made up 0.03% of Fieldpoint Private Securities's portfolio in Q2 2022, its #382 holding.
Fieldpoint Private Securities first reported a position in Gilead Sciences in Q1 2017 and has held it in 18 quarters since.
Fieldpoint Private Securities's Gilead Sciences position peaked at $355K in Q3 2017.
1,604 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.